Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Biol Ther. 2013 Apr;14(4):370-7. doi: 10.4161/cbt.23718. Epub 2013 Jan 29.

The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.

Author information

  • 1Department of Hematology, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.

Abstract

BACKGROUND:

Aberrant expression of the RON receptor tyrosine kinase is associated with tumor progression and carcinogenesis. The aims of this study were to determine the role and functional mechanisms of RON in Burkitt lymphoma (BL) and to document its potential as a therapeutic target.

METHODS:

RON expression was determined in BL cell lines by western blot analysis and examined in human lymphoma specimens by both western blotting and immunohistochemistry. The correlation between RON expression and Epstein-Barr virus (EBV) infection was investigated. Raji cells were treated with the Zt/f2 anti-RON mAb and cell viability, colony formation, apoptosis and cell cycle arrest were measured in vitro using cell proliferation assays, colony-forming assays and flow cytometry. Downregulation of RON by Zt/f2 was validated in mice bearing Raji cell xenografts.

RESULTS:

Immunohistostaining showed a high frequency of RON (+) cells in BL tissues and RON expression strongly correlated with EBV positivity. RON downregulation significantly decreased cell proliferation and colony formation via promotion of apoptosis and cell cycle arrest in Raji cells. The in vivo study showed that RON knockdown inhibits the tumorigenic potential of Raji cells in nude mice.

CONCLUSIONS:

RON acts as an oncogene in the carcinogenesis and progression of BL and is therefore a potential target for therapeutic intervention.

KEYWORDS:

Burkitt lymphoma; RON; mechanism; monoclonal antibody; oncogenic signal transduction; receptor tyrosine kinase; targeted therapy

PMID:
23360784
[PubMed - indexed for MEDLINE]
PMCID:
PMC3667878
Free PMC Article

Images from this publication.See all images (5)Free text

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Landes Bioscience Icon for PubMed Central
    Loading ...
    Write to the Help Desk